Clinical Trials Logo

Tachycardia clinical trials

View clinical trials related to Tachycardia.

Filter by:

NCT ID: NCT01791543 Completed - Clinical trials for Ventricular Tachycardia

Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable because some people have ventricular arrhythmias that originate deep within the heart muscle where it is not abolished by ablation with standard catheters. The investigators seek to determine whether the INA catheter can potentially help people who have ventricular arrhythmias that have failed standard radiofrequency ablation. The investigators also want to determine if it is likely to be safe, without excessive side effects.

NCT ID: NCT01790841 Completed - Heart Failure Clinical Trials

DF4 Master Study (Safety and Efficacy Study)

Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of the study is to proof the safety and efficacy of the new ICD sytem (Iforia/Ilesto). The devices are available with DF-1 and DF4 connection. A special focus is set on the ICD system with DF4 connection.

NCT ID: NCT01783288 Active, not recruiting - Clinical trials for Postural Tachycardia Syndrome

Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether patients meet criteria for Postural Tachycardia Syndrome (or not) and have reduced blood volume (or not). Both of these are important screening elements to Aim 3 of a National Institutes of Health Grant. The purposes of Aim 3 are to determine 1. whether a high dietary sodium level appropriately expands plasma volume in Postural Orthostatic Tachycardia, 2. whether plasma renin activity and aldosterone are modified appropriately by changes in dietary sodium in Postural Tachycardia Syndrome and 3. whether patients with Postural Tachycardia Syndrome have improvements in their orthostatic tachycardia and symptoms as a result of a high dietary sodium level.

NCT ID: NCT01780311 Recruiting - Clinical trials for Ventricular Tachycardia

Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

AVATAR
Start date: January 2013
Phase: Phase 4
Study type: Interventional

A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs for outflow tract ventricular arrhythmias

NCT ID: NCT01774357 Completed - Heart Failure Clinical Trials

Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems

MATRIX
Start date: January 2013
Phase:
Study type: Observational [Patient Registry]

This is an observational registry study aiming to collect data on efficacy and safety of the single chamber Biotronik DX system with enhanced atrial diagnostics. The minimal follow-up period is 24 months. All analyses on the data will be done post-hoc; the study does not intend to confirm any pre-specified hypotheses.

NCT ID: NCT01772576 Completed - Tachycardia Clinical Trials

Safety and Performance Study of the Reliance 4-Front Lead

Start date: October 2012
Phase: N/A
Study type: Interventional

The objective of this study is to gather data to establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONTâ„¢ Active Fixation Defibrillation Leads.

NCT ID: NCT01771484 Terminated - Clinical trials for Postural Orthostatic Tachycardia Syndrome

High Sodium Diet and External Abdominal Compression in POTS

Start date: December 2012
Phase: Phase 1
Study type: Interventional

The investigators will test to determine if an external Automated Abdominal Binder (non-commercial product) during high sodium diet improves orthostatic tolerance, compared to wearing the binder during a low sodium diet session.

NCT ID: NCT01767220 Recruiting - Clinical trials for Ventricular Tachycardia

Endo- and Epicardial vs. Endocardial Ablation of Ventricular Tachycardia in Patients With Cardiac Disease

VTeee
Start date: November 2012
Phase: N/A
Study type: Interventional

A significant portion of patients with cardiac diseases like coronary artery disease (CAD), dilated cardiomyopathy (DCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC) develops ventricular tachycardia (VT). The standard ablation procedure is carried out from endocardial only. In 30% of patients treated this way a successful ablation is not possible. In these cases the scar areas are mostly located in the outer layer of the myocardium. Ablation is feasible only if the catheter is placed in the epicardial space to reach the surface of the heart muscle. In the past this type of ablation was performed as a second procedure in case of recurrent VTs after unsuccessful endocardial ablation. This prospective randomized trial compares the standard ablation procedure (endocardial ablation only) with a new strategy. This means in a single procedure the scar areas responsible for VT are marked and obliterated from endocardial as well as from epicardial. The primary endpoint is recurrence of VT after endo- and epicardial vs. endocardial ablation only. 40 patients will be enrolled. They will be randomized 1:1 in the study arms "strategy 1" which is standard endocardial ablation and "strategy 2" which is endo- and epicardial ablation. At least 12 months are planned for enrollment. The study is closed if the patient last enrolled has completed the 12-months-follow up. Follow up visits are scheduled 3, 6 and 12 months after the ablation procedure. Recurrence of VT is monitored by ICD (implanted cardioverter defibrillator) interrogation. Both ablation strategies are well established and conducted with standard equipment. The methodology of this study does not contain any experimental approaches. The standard insurance coverage of the hospital is guaranteed for all enrolled patients.

NCT ID: NCT01764711 Completed - Clinical trials for Postural Tachycardia Syndrome

Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)

Start date: January 2013
Phase: N/A
Study type: Interventional

This study is to determine different chemical levels in the blood during a low salt diet. This study will compare normal volunteers to those with Postural Tachycardia Syndrome (POTS)

NCT ID: NCT01761825 Enrolling by invitation - Clinical trials for Postural Tachycardia Syndrome

The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome

Start date: December 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Ivabradine is an effective treatment for postural tachycardia syndrome.